NPPA allows Glenmark to price its Digital dose Counter, Digihale Medical Dialogues Team22 March 2021 7:04 PM ISTNew Delhi: Pharma major Glenmark has secured the National Pharmaceutical Pricing Authority's (NPPA) approval to revise the price of Digital Dose...
Drug majors including Cipla, Sun Pharma, Pfizer, others owe Rs 6,550 crore overcharged amount : NPPA Farhat Nasim29 Jan 2021 6:44 PM ISTNew Delhi: Several drug majors including Cipla, Ranbaxy, Lupin, Glenmark, Sun Pharma have been accused of overcharging consumers to the tune of...
Glenmark gets CDSCO panel conditional nod to Minocycline Hydrochloride Topical Gel MD Bureau26 Jan 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has opined for the grant of...
NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch Farhat Nasim15 Jan 2021 7:06 PM ISTNew Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...
Glenmark, Menarini ink licensing pact for Ryaltris Nasal Spray in European market Ruchika Sharma24 Dec 2020 12:19 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. has recently announced that the company's Swiss subsidiary, Glenmark Specialty S.A., has entered into an ...
Dr Reddy's Labs to acquire select anti-allergy brands of Glenmark Farhat Nasim29 Nov 2020 4:09 PM ISTThe acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine, which are indicated for...
Glenmark gets USFDA nod for generic Prograf Capsules Ruchika Sharma11 Nov 2020 12:08 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA today announced that the company has been granted final approval by the United States Food & Drug...
Glenmark reports net profit at Rs 234 crore in Q2 Ruchika Sharma9 Nov 2020 9:00 AM ISTNew Delhi: Drug firm Glenmark Pharmaceuticals on Friday reported a consolidated net profit of Rs 233.99 crore for the second quarter ended...
Death During Glenmark Favipiravir-Umifenovir Trial: CDSCO seeks adverse event report Farhat Nasim15 Oct 2020 12:34 PM ISTNew Delhi: The Mumbai-based drugmaker, Glenmark Pharmaceuticals Ltd., has been directed by the apex drug regulator, Central Drugs Standard Control...
Glenmark launches pulmonary fibrosis drug NINDANIB in India Ruchika Sharma14 Oct 2020 1:00 PM ISTNintedanib is approved by the Indian drug regulator for the treatment of Idiopathic (unknown cause) Pulmonary Fibrosis (IPF).
CDSCO expert panel rejects Glenmark Favipiravir-Dexamethasone combination for COVID treatment Farhat Nasim11 Oct 2020 11:30 AM ISTNew Delhi: In a major setback to Glenmark, the Subject Expert Committee of the apex the drug regulator, Central Drugs Standard Control Organisation...
Combining Umifenovir, Favipiravir for mild COVID treatment did not show benefit: Glenmark MD Bureau9 Oct 2020 9:05 PM ISTThe addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients, Glenmark said.
